TrialJAMA network open2022

Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.

Cynthia Portal-Celhay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.